Summary
Updated Aug 31, 2026
Judith L. Swain is Director of LEXICON PHARMACEUTICALS, INC. (LXRX). 4 SEC Form 4 filings on record going back to 2025, most recently on 4 June 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Judith L. Swain has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Judith L. Swain files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Invus Global Management, LLC - $2.00M of LXRX open-market activity in the last 12 months
- Raymond Debbane - $723K of LXRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Judith L. Swain?
Judith L. Swain is a corporate insider, tracked as Director of LEXICON PHARMACEUTICALS, INC. (LXRX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Judith L. Swain submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Judith L. Swain's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Judith L. Swain and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
